Gray G, Chukwuma P, Eldaly B, Perera W, Brambley C, Rosales T
Immunol Rev. 2025; 329(1):e13439.
PMID: 39804137
PMC: 11771984.
DOI: 10.1111/imr.13439.
Singh N, Alonso J, Devlin J, Keller G, Gray G, Chiranjivi A
Nat Commun. 2022; 13(1):7189.
PMID: 36424374
PMC: 9691722.
DOI: 10.1038/s41467-022-34896-0.
Krabbendam L, Heesters B, Kradolfer C, Haverkate N, Becker M, Buskens C
Nat Commun. 2021; 12(1):5841.
PMID: 34615883
PMC: 8494908.
DOI: 10.1038/s41467-021-26187-x.
Krabbendam L, Heesters B, Kradolfer C, Spits H, Bernink J
Eur J Immunol. 2020; 51(4):811-823.
PMID: 33300130
PMC: 8248192.
DOI: 10.1002/eji.202048696.
Tollefsen S, Arentz-Hansen H, Fleckenstein B, Molberg O, Raki M, Kwok W
J Clin Invest. 2006; 116(8):2226-36.
PMID: 16878175
PMC: 1518792.
DOI: 10.1172/JCI27620.
Major histocompatibility complex class I-restricted alloreactive CD4+ T cells.
Boyle L, Goodall J, Gaston J
Immunology. 2004; 112(1):54-63.
PMID: 15096184
PMC: 1782457.
DOI: 10.1111/j.1365-2567.2004.01857.x.
Dual HLA class I and class II restricted recognition of alloreactive T lymphocytes mediated by a single T cell receptor complex.
Heemskerk M, de Paus R, Lurvink E, Koning F, Mulder A, Willemze R
Proc Natl Acad Sci U S A. 2001; 98(12):6806-11.
PMID: 11381117
PMC: 34434.
DOI: 10.1073/pnas.111162298.
Generation of alphabeta T-cell receptor+ CD4- CD8+ cells in major histocompatibility complex class I-deficient mice upon activation of the aryl hydrocarbon receptor by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Kronenberg S, Lai Z, Esser C
Immunology. 2000; 100(2):185-93.
PMID: 10886394
PMC: 2326997.
DOI: 10.1046/j.1365-2567.2000.00022.x.
Activation of virus-specific major histocompatibility complex class II-restricted CD8+ cytotoxic T cells in CD4-deficient mice.
Heemskerk M, Schilham M, Schoemaker H, Spierenburg G, Spaan W, Boog C
Eur J Immunol. 1995; 25(4):1109-12.
PMID: 7737281
PMC: 7163489.
DOI: 10.1002/eji.1830250438.
Idiotypic diversity and variable region gene usage by mouse anti-HLA-DQ3 mAb.
Iwasaki Y, Takabatake H, Monestier M, Ferrone S
Immunogenetics. 1995; 42(2):90-100.
PMID: 7607710
DOI: 10.1007/BF00178583.
Newer lymphocyte surface antigens.
Schiffenbauer J, Schwartz B
Surv Immunol Res. 1984; 3(2-3):91-5.
PMID: 6232679
DOI: 10.1007/BF02918770.
Natural killer cells activated in a human mixed lymphocyte response culture identified by expression of Leu-11 and class II histocompatibility antigens.
Phillips J, Le A, Lanier L
J Exp Med. 1984; 159(4):993-1008.
PMID: 6231353
PMC: 2187263.
DOI: 10.1084/jem.159.4.993.
Effect of interferon-gamma on class-II antigen expression and accessory cell function.
Becker S
Surv Immunol Res. 1985; 4(2):135-45.
PMID: 3929353
DOI: 10.1007/BF02918809.
Differences in antigen presentation to MHC class I-and class II-restricted influenza virus-specific cytolytic T lymphocyte clones.
Morrison L, Lukacher A, Braciale V, Fan D, Braciale T
J Exp Med. 1986; 163(4):903-21.
PMID: 3485173
PMC: 2188068.
DOI: 10.1084/jem.163.4.903.
Virus-immune T cells and the major histocompatibility complex: evolution of some basic concepts over the past two years.
Doherty P
Experientia. 1986; 42(9):972-7.
PMID: 3093266
DOI: 10.1007/BF01940699.
T-cell clones and T-cell receptors.
Fitch F
Microbiol Rev. 1986; 50(1):50-69.
PMID: 3083221
PMC: 373053.
DOI: 10.1128/mr.50.1.50-69.1986.
Expression of specific cytolytic activity by H-2I region-restricted, influenza virus-specific T lymphocyte clones.
Lukacher A, Morrison L, Braciale V, Malissen B, Braciale T
J Exp Med. 1985; 162(1):171-87.
PMID: 2409206
PMC: 2187708.
DOI: 10.1084/jem.162.1.171.
The human T-cell receptor.
Acuto O, Fabbi M, Bensussan A, Milanese C, Campen T, Royer H
J Clin Immunol. 1985; 5(3):141-57.
PMID: 2409103
DOI: 10.1007/BF00915505.
Characterization of the lymphocyte activation gene 3-encoded protein. A new ligand for human leukocyte antigen class II antigens.
Baixeras E, Huard B, Miossec C, JITSUKAWA S, Martin M, Hercend T
J Exp Med. 1992; 176(2):327-37.
PMID: 1380059
PMC: 2119326.
DOI: 10.1084/jem.176.2.327.
